Am J Physiol Cell Physiol Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 276: C176-C181, 1999;
0363-6143/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cunningham, S. A.
Right arrow Articles by Brock, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cunningham, S. A.
Right arrow Articles by Brock, T. A.
Vol. 276, Issue 1, C176-C181, January 1999

KDR activation is crucial for VEGF165-mediated Ca2+ mobilization in human umbilical vein endothelial cells

Sonia A. Cunningham1,2, Tuan M. Tran1, M. Pia Arrate1, Robert Bjercke1, and Tommy A. Brock1

1 Department of Pharmacology, Texas Biotechnology Corporation, Houston, 77030; and 2 Department of Integrative Biology, Pharmacology, and Physiology, University of Texas Health Science Center, Houston, Texas 77225

We have prepared a polyclonal mouse antibody directed against the first three immunoglobulin-like domains of the kinase insert domain-containing receptor (KDR) tyrosine kinase. It possesses the ability to inhibit binding of the 165-amino acid splice variant of vascular endothelial cell growth factor (VEGF165) to recombinant KDR in vitro as well as to reduce VEGF165 binding to human umbilical vein endothelial cells (HUVEC). These results confirm that the first three immunoglobulin-like domains of KDR are involved in VEGF165 interactions. The anti-KDR antibody is able to completely block VEGF165-mediated intracellular Ca2+ mobilization in HUVEC. Therefore, it appears that binding of VEGF165 to the fms-like tyrosine kinase (Flt-1) in these cells does not translate into a Ca2+ response. This is further exemplified by the lack of response to placental growth factor (PlGF), an Flt-1-specific ligand. Additionally, PlGF is unable to potentiate the effects of submaximal concentrations of VEGF165. Surprisingly, the VEGF-PlGF heterodimer was also very inefficient at eliciting a Ca2+ signaling event in HUVEC. We conclude that KDR activation is crucial for mobilization of intracellular Ca2+ in HUVEC in response to VEGF165.

tyrosine kinase; neutralizing antibodies; kinase insert domain-containing receptor; vascular endothelial cell growth factor


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
B. M. Prior, H. T. Yang, and R. L. Terjung
What makes vessels grow with exercise training?
J Appl Physiol, September 1, 2004; 97(3): 1119 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. P. McLaughlin and G. W. De Vries
Role of PLCgamma and Ca2+ in VEGF- and FGF-induced choroidal endothelial cell proliferation
Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1448 - C1456.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
I. Zachary
Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor
Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1375 - C1386.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
L. Jiang, V. Jha, M. Dhanabal, V. P. Sukhatme, and S. L. Alper
Intracellular Ca2+ signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin
Am J Physiol Cell Physiol, May 1, 2001; 280(5): C1140 - C1150.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B.-Q. Shen, D. Y. Lee, and T. F. Zioncheck
Vascular Endothelial Growth Factor Governs Endothelial Nitric-oxide Synthase Expression via a KDR/Flk-1 Receptor and a Protein Kinase C Signaling Pathway
J. Biol. Chem., November 12, 1999; 274(46): 33057 - 33063.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. N. Bernatchez, S. Soker, and M. G. Sirois
Vascular Endothelial Growth Factor Effect on Endothelial Cell Proliferation, Migration, and Platelet-activating Factor Synthesis Is Flk-1-dependent
J. Biol. Chem., October 22, 1999; 274(43): 31047 - 31054.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online